Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 1
2009 2
2010 4
2011 2
2012 4
2013 5
2014 6
2015 7
2016 13
2017 15
2018 17
2019 23
2020 19
2021 17
2022 13
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 32532926

118 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of modified Response Evaluation Criteria in Solid Tumors, European Organization for Research and Treatment of Cancer criteria, and PET Response Criteria in Solid Tumors for evaluation of tumor response to chemotherapy and prognosis prediction in patients with unresectable malignant pleural mesothelioma.
Kitajima K, Maruyama M, Minami T, Yokoi T, Kuribayashi K, Kijima T, Hashimoto M, Hasegawa S, Yamakado K. Kitajima K, et al. Nucl Med Commun. 2020 Aug;41(8):790-799. doi: 10.1097/MNM.0000000000001223. Nucl Med Commun. 2020. PMID: 32516245
Prognostic and predictive role of [18 F]fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up-front pemetrexed-based chemotherapy.
Zucali PA, Lopci E, Ceresoli GL, Giordano L, Perrino M, Ciocia G, Gianoncelli L, Lorenzi E, Simonelli M, De Vincenzo F, Setti LR, Bonifacio C, Bonomi M, Bombardieri E, Chiti A, Santoro A. Zucali PA, et al. Cancer Med. 2017 Oct;6(10):2287-2296. doi: 10.1002/cam4.1182. Epub 2017 Sep 21. Cancer Med. 2017. PMID: 28941158 Free PMC article.
18F-FDG PET/CT in therapy response and in predicting responders or non-responders in malignant pleural mesothelioma patients, by using semi-quantitative mRECIST and EORTC criteria.
Niccoli Asabella A, Di Palo A, Altini C, Fanelli M, Ferrari C, Lavelli V, Ranieri G, Gadaleta CD, Rubini G. Niccoli Asabella A, et al. Hell J Nucl Med. 2018 Sep-Dec;21(3):191-197. doi: 10.1967/s002449910904. Epub 2018 Nov 10. Hell J Nucl Med. 2018. PMID: 30411729 Free article.
Tumor response evaluation in patients with malignant melanoma undergoing immune checkpoint inhibitor therapy and prognosis prediction using 18F-FDG PET/CT: multicenter study for comparison of EORTC, PERCIST, and imPERCIST.
Kitajima K, Watabe T, Nakajo M, Ishibashi M, Daisaki H, Soeda F, Tanemura A, Kanekura T, Yamazaki N, Ito K. Kitajima K, et al. Jpn J Radiol. 2022 Jan;40(1):75-85. doi: 10.1007/s11604-021-01174-w. Epub 2021 Jul 21. Jpn J Radiol. 2022. PMID: 34287739 Free PMC article.
118 results